About Indivior PLC
https://www.indivior.comIndivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
CEO
Joseph J. Ciaffoni
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2022-10-17 | Reverse | 1:5 |
| 2022-10-10 | Reverse | 1:5 |
ETFs Holding This Stock
Summary
Showing Top 3 of 105
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
OAKTREE CAPITAL MANAGEMENT LP
Shares:257.79M
Value:$8.67B
TWO SEAS CAPITAL LP
Shares:10.5M
Value:$353.25M
BLACKROCK, INC.
Shares:8.73M
Value:$293.56M
Summary
Showing Top 3 of 202
About Indivior PLC
https://www.indivior.comIndivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $314M ▲ | $187M ▲ | $42M ▲ | 13.38% ▲ | $0.34 ▲ | $51M ▼ |
| Q2-2025 | $302M ▲ | $178M ▲ | $18M ▼ | 5.96% ▼ | $0.14 ▼ | $82M ▲ |
| Q1-2025 | $266M ▼ | $156M ▼ | $47M ▼ | 17.67% ▼ | $0.38 ▼ | $76M ▼ |
| Q4-2024 | $299M ▼ | $180M ▼ | $59M ▲ | 19.73% ▲ | $0.45 ▲ | $106M ▲ |
| Q3-2024 | $307M | $234M | $4M | 1.3% | $0.03 | $22M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $445M ▼ | $1.42B ▼ | $1.62B ▼ | $-207M ▲ |
| Q2-2025 | $510M ▲ | $1.45B ▲ | $1.71B ▲ | $-258M ▲ |
| Q1-2025 | $373M ▲ | $1.38B ▲ | $1.66B ▼ | $-286M ▲ |
| Q4-2024 | $320M ▲ | $1.32B ▼ | $1.67B ▲ | $-348M ▼ |
| Q3-2024 | $318M | $1.46B | $1.63B | $-167M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $42M ▲ | $-41.96M ▼ | $-20.43M ▼ | $-3M ▲ | $-65M ▼ | $-62.4M ▼ |
| Q2-2025 | $18M ▼ | $166.04M ▲ | $-18.69M ▼ | $-4.63M ▲ | $138M ▲ | $148.38M ▲ |
| Q1-2025 | $47M ▲ | $75M ▲ | $-5M ▼ | $-17M ▼ | $53M ▲ | $70M ▲ |
| Q4-2024 | $20M ▲ | $-5.65M ▼ | $9.12M ▼ | $29.07M ▲ | $31M ▲ | $-21.49M ▼ |
| Q3-2024 | $3M | $8M | $32M | $-55M | $-14M | $-1M |
CEO
Joseph J. Ciaffoni
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2022-10-17 | Reverse | 1:5 |
| 2022-10-10 | Reverse | 1:5 |
ETFs Holding This Stock
Summary
Showing Top 3 of 105
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
OAKTREE CAPITAL MANAGEMENT LP
Shares:257.79M
Value:$8.67B
TWO SEAS CAPITAL LP
Shares:10.5M
Value:$353.25M
BLACKROCK, INC.
Shares:8.73M
Value:$293.56M
Summary
Showing Top 3 of 202